Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000899243-15-005097

See Remarks sold 1,809 shares at $6.33 ($11,451)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BRISTOW MICHAEL R See Remarks 2015-09-18 Sale −1,809 $6.33 $11,451 46,086 D: show line 1 in the form
Open-market sales · 1,809 sh · avg $6.33 · $11,451
Loading xslF345X03/doc4.xml…